Transfer of antivirals across the human placenta

Early Human Development

Volumn 81, Issue 8, 2005, Pages 647-654

  Pacifici, Gian Maria ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Abacavir; Acyclovir; Amprenavir; Antivirals; Didanosine Zalcitabine; Ganciclovir; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Placenta; Placental transfer; Ritonavir; Saquinavir; Stavudine; Zidovudine

Indexed keywords

ABACAVIR; ACICLOVIR; ALPHA INTERFERON; AMPRENAVIR; ANTIVIRUS AGENT; BISHETEROPIPERAZINE; DIDANOSINE; GANCICLOVIR; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

CYTOMEGALOVIRUS; DRUG ABSORPTION; DRUG CLEARANCE; FETUS CIRCULATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; IN VIVO STUDY; LITERATURE; MEDLINE; PLACENTA; PLACENTAL TRANSFER; REVIEW; UMBILICAL CORD;

ANIMALS; ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; MOLECULAR WEIGHT; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 23044491688     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2005.02.002     Document Type: Review

References (52)

1. M.J. Oxtoby Perinatal acquired human immunodeficiency virus infection Pediatr Infect Dis J 9 1990 609 619
2. World Health Organisation Global Programme on AIDS: current and future dimension of the HIV/AIDS pandemic: a capsule summary. Geneva WHO; January 1992.
3. P. Duff HIV infection in women Prim Care Update Ob Gyns 3 1996 45 49
4. Y. Bryson Perinatal HIV-1 transmission: recent advances and therapeutic interventions AIDS 10 1996 S33 S42
5. G.C. John, and J. Kreiss Mother-to-child transmission of HIV Epidemiol Rev 18 1996 149 157
6. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. December 17, 1994. From the internet: http://aidsinfo.nih.gov.
7. S.A. Fiscus, A.A. Adimora, M.L. Funk, V.J. Schoenbach, D. Tristram, and W. Lim Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina Pediatr Infect Dis J 21 2002 664 668
8. M. Lallemant, G. Jourdain, S. Le Coeur, S. Kim, S. Koetsawang, and A.M. Comeau A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators N Engl J Med 343 2000 982 991
9. R.E. Tuomala, D.E. Shapiro, L.M. Mofenson, Y. Bryson, M. Culnane, and M.D. Hughes Antiretroviral therapy during pregnancy and the risk of an adverse outcome N Engl J Med 346 2002 1863 1870
10. E.M. Connor, R.S. Sperling, R. Gelber, R. Kiselev, M. Bey, and W. Shearer Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Engl J Med 331 1994 1173 1180
11. European Collaborative Study HIV-infected pregnant women and vertical transmission in Europe since 1986 AIDS 15 2001 761 770
12. L. Mandelbrot, Landreau-Mascaro, C. Rekacewics, A. Berebbi, J.L. Benifla, and M. Burgard Agence Nationale de Recherches sur le SIDA (ANRS) 075 Group. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1 JAMA 285 2001 2129 2131
13. M. Mirochnick Antiretroviral pharmacology in pregnant women and their newborns Ann N Y Acad Sci 918 2000 287 297
14. D.M. Money Antiviral and antiretrovirals use in pregnancy Obstet Gynecol Clin North Am 30 2003 731 749
15. G.M. Pacifici, and R. Nottoli Placental transfer of drugs administered to the mother Clin Pharmacokinet 28 1995 235 269
16. H. Schneider, M. Panigel, and J. Dancis Transfer across the perfused human placenta of antipyrine, sodium and leucine Am J Obstet Gynecol 114 1972 822 828
17. R.K. Miller, P.J. Wier, R. Perez-D'Gregorio, C. Eisenmann, P.A. di Sant'agnese, and Y. Shah Human and dual placenta perfusion-criteria for toxicity evaluations Methods Toxicol 3B 1993 246 259
18. R.K. Miller, P.J. Wier, D. Maulik, and P.A. di Sant'Agnese Human placenta in vitro: characterisation during 12 hours of dual perfusion Contrib Gynecol Obstet 13 1985 77 84
19. J.C. Challier Criteria for evaluating perfusing experiments and presentation of the results Contrib Gynecol Obstet 13 1985 32 39
20. F.G. Hayden Antiviral agents J.G. Hardman L.E Limbrid Gilman A. Goodman Goodman and Gilman's the pharmacological basis of therapeutics 10th ed. 2001 McGrow-Hill New York 1313 1347
21. S. Raffanti, and D.W. Haas Antiretroviral agents J.G. Hardman L.E. Limbrid Gilman A. Goodman Goodman and Gilman's the pharmacological basis of therapeutics 10th ed. 2001 McGrow-Hill New York 1349 1380
22. K.E. Thummel, and D.D. Shen Design and optimization of dosage regimens: pharmacokinetic data J.G. Hardman L.E. Limbrid Gilman A. Goodman Goodman and Gilman's the pharmacological basis of therapeutics 10th ed. 2001 McGraw-Hill New York 1917 2023
23. T. Tuntland, A. Odinecs, C.M. Pereire, C. Nosbisch, and J.D. Unadkat In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleotide drug against human immunodeficiency virus Am J Obstet Gynecol 180 1999 198 206
24. E. Chappuy, J.M. Treluyer, E. Rey, J. Dime, M. Fouché, and G. Firtion Maternal fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with immunodeficiency virus Am J Obstet Gynecol 191 2004 558 562
25. G.I. Henderson, Z.Q. Hu, R.F. Johnson, A.B. Perez, Y. Yang, and S. Schenker Acyclovir transport by the human placenta J Lab Clin Med 120 1992 885 892
26. L.C. Gilstrap, R.E. Bawdone, S.W. Roberts, and S. Sobhi The transfer of the nucleoside analogue ganciclovir across the perfused human placenta Am J Obstet Gynecol 170 1994 967 973
27. G.I. Henderson, Z.Q. Hu, Y. Yang, T.B. Perez, B.G. Devi, and T.A. Frosto Ganciclovir transfer by human placenta and its effects on rat fetal cells Am J Med Sci 306 1993 151 156
28. R.E. Bawdon, S. Sobhi, and J. Dax The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta Am J Obstet Gynecol 167 1992 1570 1574
29. G.I. Henderson, A.B. Perez, Y. Yang, R.L. Hamby, R.S. Schenken, and S. Scenker Transfer of didanosine across the human placenta Br J Clin Pharmacol 38 1994 237 242
30. European Collaborative Study Exposure to antiviral therapy in utero or early life: the heath of uninfected children born to HIV-infected women J Acquir Immune Defic Syndr 32 2003 380 387
31. N. Rakhmanina, J.N. van Den Anker, and S.J. Soldin Safety and pharmacokinetics of antiretroviral therapy during pregnancy Ther Drug Monit 26 2004 110 115
32. J.C. Pons, M.C. Boubon, A.M. Taburet, E. Singlas, V. Chambrin, and R. Frydman Fetoplacental passage of 2′,3′-dideoxyinosine Lancet 337 1991 732
33. H. Chappuy, J.M. Treluyer, V. Julien, J. Dimet, E. Rey, and M. Fouche Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women Antimicrob Agents Chemother 48 2004 4332 4336
34. M. Mirochnick, T. Fenton, P. Gangier, J. Pav, M. Gwynne, and S. Siminski Pharmacokinetics of nevirapine in human immunodeficiency virus type 1 infected pregnant women and their neonates J Inf Disp 178 1998 368 374
35. C. Marzolini, C. Rudin, L.A. Decosterd, A. Telenti, A. Schreyer, and J. Biollaz Transplacental passage of protease inhibitors at delivery AIDS 16 2002 889 893
36. R.S. Sperling, D.E. Shapiro, R.W. Coombs, J.A. Tood, S.A. Herman, and G.D. McSherry Maternal viral load, zidovudine treatment, and risk of transmission of human immunodeficiency virus type 1 from mother to infant N Engl J Med 335 1996 1621 1629
37. L. Liebes, S. Mendoza, D. Wilson, and J. Dancis Transfer of zidovudine (AZT) by human placenta J Inf Disp 161 1990 203 207
38. M. Mirochnick, A. Dorenbaum, D. Holland, B. Cunningham-Schrader, C. Cunningham, and R. Gelbert Concentration of protease inhibitors in cord blood after in utero exposure Pediatr Infect Dis J 21 2002 835 838
39. S. Schenker, R.F. Johnson, T.S. King, R.S. Shenken, and G.I. Henderson Azidothymidine (zidovudine) transport by the human placenta Am J Med Sci 299 1990 16 20
40. R.E. Bawdon, S. Kaul, and S. Sobht The ex vivo transfer of the anti-HIV nucleoside compound d4T in the human placenta Gynecol Obstet Invest 38 1994 1 4
41. S.L. Bloom, K.M. Dias, R.E. Bawdon, and L.G. Gilstrap The maternal-fetal transfer of lamivudine in the ex vivo human placenta Am J Obstet Gynecol 176 1997 291 293
42. R.E. Bawdon The ex vivo human placental transfer of the anti-HIV nucleoside abacavir and the protease inhibitor amprenavir Inf Dis Obstet Gynecol 6 1998 244 246
43. S. Roberts, R. Bawdon, S. Sobhi, J. Dax, L. Gilstrap, and D. Wimberly The maternal-fetal transfer of bisheteroypiperazine (U-87201-E) in the ex vivo human placenta Am J Obstet Gynecol 172 1995 88 91
44. F. Forestier, P. De Renty, G. Peytavin, E. Dohin, R. Farinotti, and L. Mandelbrot Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model Am J Obstet Gynecol 185 2001 178 181
45. B.M. Casey, and R.E. Bawdon Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model Am J Obstet Gynecol 179 1998 758 761
46. A. Waysbort, M. Giroux, V. Mansat, M. Teixeira, J.C. Dumas, and J. Puel Experimental study of transplacental passage of alpha interferon by two assay techniques Antimicrob Agents Chemother 37 1993 1232 1237
47. M.J. O'Sullivan, P.J.J. Boyer, G.B. Scott, W.P. Parks, S. Weller, M.R. Blum the Zidovudine Collaborating Working Group The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082) Am J Obstet Gynecol 168 1993 1510 1516
48. J.Y. Gillet, R. Garraffo, D. Abrar, A. Bongain, P. Lapalus, and P. Dellamonica Fetoplacental passage of zidovudine Lancet ii 1989 269 270
49. J.C. Pons, A.M. Taburet, E. Singlas, J.F. Delfraissy, and E. Papiernik Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound Eur J Obstet Gynecol Reprod Biol 40 1991 229 231
50. C. Bhadrakom, R.J. Simonds, J.V. Mei, S. Asavapiriyanont, V. Sangtaweesin, and N. Vanprapar Oral zidovudine during labour to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood AIDS 14 2000 509 516
51. L. Mandelbrot, G. Peytavin, G. Firtion, and R. Farinotti Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women Am J Obstet Gynecol 184 2001 153 158
52. L.M. Frenkel, Z.A. Brown, Y.J. Bryson, L. Corey, J.D. Unadkat, and P.A. Hensleigh Pharmacokinetics of acyclovir in the term human pregnancy and neonate Am J Obstet Gynecol 164 1991 569 576